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Abstract: Long-term radiotherapy-related complications in children with head and neck can-
cer have been frequently reported, especially facial growth disorders and dental abnormalities. 
We report on two male children (8 and 14 years old) with head and neck cancer, who were 
successfully treated with chemoradiotherapy and presented with growth deﬁ  ciency of middle 
face and mandible hypoplasia, eight years and one year later, respectively. These severe growth 
complications attributed to chemoradiotherapy, while the patients survived primary malignancy. 
Patient age at irradiation was signiﬁ  cantly correlated with the severity of disorders. We consider 
late sequelae in children with head and neck cancer due to chemoradiotherapy another era for 
pediatric oncologic pathology for prevention, if possible, or to manage them efﬁ  ciently.
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Introduction
Nasopharyngeal carcinoma (NPC) is scarcely reported in children,1–3 more often of 
undifferentiated type, while combined chemoradiotherapy constitutes the treatment 
of choice for this malignancy with promising results.3–5 Overall survival between 
50% and 77% is reported.2–4 However, the high radiation doses needed to be effec-
tive, resulted in long-term toxicity with hard and soft tissues growth complications, 
particularly in young children that still present growth potential.4,5 Particularly, facial 
growth retardation, dental abnormalities, visual/orbital problems, neuroendocrine 
dysfunction, cognitive toxicity, and hypothyroidism have been reported in children 
with head and neck cancer post-irradiation.6,7 Patient age at irradiation is signiﬁ  cantly 
correlated with the severity of disorders.8,9 Xerostomia, oral mucositis, late visual and 
auditory toxicity have also been reported as frequent and potentially severe complica-
tions of radiotherapy.10,11
The idea of pediatric oncologic pathology has been recently proposed by Lacey 
and Clarke,12 who reported on two children with leukemia, treated with combined 
radiotherapy and chemotherapy, survived from malignancy but suffered in long-term 
from bilateral slipped capital femoral epiphyses (SCPE) or bilateral avascular femoral 
head necrosis, respectively, as a consequence of radiochemotherapy.
We would like to further report on two male children (8 and 14 years old) with head 
and neck cancer, who were successfully treated with combined chemoradiotherapy, 
survived malignancy, but presented with growth deﬁ  ciency of middle face and man-
dible hypoplasia, eight years and one year later, respectively.
Case report A
A 16-year-old male presented to the outpatient radiotherapy–oncology department, 
with severe growth deﬁ  ciency of middle and lower face (Pierre Robin-like syndrome), International Journal of General Medicine 2009:2 64
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mandible hypoplasia, and poor oral hygiene for further 
evaluation and treatment. He had an eight-year known history 
of nasopharyngeal undifferentiated squamous cell carcinoma 
(NPC), histologically diagnosed (according to World Health 
Organization, Type II cΤ3cN3T0, grade IV).
At that time, he was successfully treated with combined 
chemoradiotherapy according to the following protocol: 
radiotherapy followed by adjuvant endoxan–ﬂ  uouracil–
vincristine chemotherapy at 28-day intervals for two years.
Radiotherapy plan was conducted by two dimensional 
(2D) computerized treatment planning system (Telemaque 
Technos, Technologies-Informatiques SA, Trappes, France). 
Primary site and bilateral upper neck received 60 Gy in 
33 fractions over 6.5 weeks and lower neck–supraclavicular 
fossae received 40 Gy in 22 fractions over 4.5 weeks. A two-
phase technique was used.
Following conventional simulation and using a Cobalt-60 
gamma rays unit, radiotherapy was initially delivered by large 
parallel-opposed lateral ﬁ  elds to a dose of 36 Gy given in four 
weeks, 180 cGy per day. Treatment ﬁ  eld extended superiorly 
to the inferior orbital margin, inferiorly to C6 spinous process, 
anteriorly to the anterior border of masseter muscle and pos-
teriorly to T2 spinous process, encompassing all macroscopic 
disease, including spinal cord. To cover undetectable micro-
scopic disease, the clinical target volume included the base of 
the skull, posterior half of nasal cavity, nasopharynx, base of 
sphenoid, para-pharyngeal space, lateral pharyngeal, posterior 
and upper deep cervical nodes. Brainstem, optic chiasm and 
anterior half of the orbit were shielded. During the second 
phase of treatment the parallel-opposed lateral ﬁ  elds were 
reduced posteriorly to exclude the spinal cord and a further 
dose of 24 Gy was given over 2.5 weeks, 180 cGy per day, 
achieving a total dose of 60 Gy in 33 fractions.
The size of the malignancy before and after treatment was 
estimated with magnetic resonance imaging (Figures 1A, B). 
A complete response both of the primary tumor and the 
locoregional lumph nodes was achieved one month after the 
end of the treatment (Figures 1C, D).
Since then he is totally asymptomatic and free of malig-
nancy. Clinical examination during the eight-year follow-up 
post-irradiation showed partial mandible mobility and open-
ing, mild xerostomia, mandible skeletal relation type II with 
mandible hypoplasia while the mouth opening was slightly 
deteriorated (higher opening diameter 35 mm). Multiple caries 
lesions were found on almost all teeth, but the lesions of the 
canines, premolars, and molars were more signiﬁ  cant. Patient’s 
oral hygiene was poor with plaque accumulation, severe local-
ized inﬂ  ammatory gingivitis, and gingival hyperplasia.
Radiological examination and cephalometric analysis 
showed sagital symmetric hypoplasia of the lower facial part, 
microgenia, maxillary protrusion in relation to the anterior 
skull base, mandibular retrusion, dolichofacial growth pat-
tern, normal lower facial height, normal mandibular length 
and posterior rotation of the mandible (clockwise rotation). 
Lower incisors were positioned in a normal distance to A/Pog 
plane, but with lingual inclination. The lower lip was found 
in posterior position in relation to the esthetic line and the 
nose seemed pronounced. Maxilla was narrow anteriorly, 
maxillary anterior teeth presented crowding and mandibular 
dental arch presented spaces distal to canines.
Mandible hypoplasia was characterized as traumatic 
post-irradiation hypoplasia of condyloid apophysis, while 
the deteriorating mouth opening attributed to periarticular 
tissue ﬁ  brosis. Oral hygiene guidelines in combination with 
tooth tissue replacement were given to our patient.
Case report B
A 15-year-old male with xerostomia was presented to the 
radiotherapy–oncology department for evaluation and 
management. The patient had one-year history of epipha-
ryngeal carcinoma successfully treated with combined 
chemoradiotherapy. He was initially administered a total 
radiation dose of 6500 rads followed by chemotherapy with 
vincristine–cyclophosphamide–5-fluouracil–abriblastine 
at 28-day intervals for six months. Radiotherapy plan was 
conducted by 2D computerized treatment planning system 
(Telemaque Technos).
Since the completion of chemoradiotherapy, he is 
totally free from malignancy. One-year post-irradiation 
clinical examination revealed decreased mouth opening, 
oral xerostomia, multiple caries lesions on almost all teeth, 
skeletal mandible relations type I and vertical dolicholic 
face with soft tissue hypoplasia of parotic area. Radiologi-
cal examination and cephalometric analysis showed lower 
normal development, with normal splachnic skull with small 
mandible corner.
Decreased mouth opening and vertical dolicholic face out-
line were attributed to post-irradiation soft tissue ﬁ  brosis and 
parotid atrophy, while the small mandible corner attributed to 
traumatic effect of radiotherapy to the cartilage of condyloid 
apophysis. Oral hygiene guidelines in combination with tooth 
tissue replacement were also given to this patient.
Discussion
Long-term radiotherapy-related complications in children 
with head and neck cancer have been frequently reported International Journal of General Medicine 2009:2 65
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Figure 1 Magnetic resonance image showing the size of malignancy before treatment with chemoradiotherapy A, B, and the response after treatment C, D.
in literature, especially facial growth retardation, dental 
abnormalities, visual/orbital problems, neuroendocrine 
dysfunction, cognitive toxicity, and hypothyroidism.6,7 
Frequency and severity of radiotherapy related effects are 
generally depended on total radiation dose, dose per session, 
type of tumor irradiated and radiation technique (treatment 
planning system). The lower harmful radiation dose reported 
is probably 1800–2000 rads.8,9 Developing bones are radio-
sensitive with a consequence of the normal development 
deteriorating post-irradiation.
Moreover, the severity of developmental disturbances 
is related to patient age and treatment onset. The younger 
the age, especially prior to six years, the more severe the 
abnormalities,8,9 as was the case in our patients. Patient A, who 
was younger (8 years old) at the time of irradiation, presented 
more severe abnormalities than patient B (14 years old). 
Particularly, in patient A, who was irradiated when aged 
eight, when dentiﬁ  cation was mixed and developmental 
activity of condyloid apophysis was also intense, more seri-
ous lesions were found, in relation to patient B, who was International Journal of General Medicine 2009:2 66
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irradiated when aged 14, when skeletal development was 
almost completed. Xerostomia, oral mucositis, late visual 
and auditory toxicity have also been reported as frequent and 
potentially severe complications of radiotherapy.10,11
Nasopharyngeal carcinoma (NPC) is extremely rare in 
children1–3 with overall survival between 50% and 77%.2–4 
Combined chemoradiotherapy constitutes the treatment of 
choice for this malignancy, with promising results,3–5 which 
was also the case in patient A. However, the high radiation 
doses administered resulted in long-term toxicity with hard 
and soft tissues growth complications (middle face deﬁ  ciency 
and mandible hypoplasia), particularly in our 8-year-old child 
who still had growth potential.4,5
Sagittal type mandible hypoplasia presents wide range 
of clinical manifestations, from slight hypoplasia to severe 
Pierre Robin-like syndrome, as in our patient A and is char-
acterized as traumatic post-irradiation symmetric severe 
hypoplasia or agenesis of condyloid apophysis. Furthermore, 
periarticular tissue ﬁ  brosis of temporomandibular articulation 
as a consequence of irradiation resulted in decreased mouth 
opening and articular motility limitation in patient A.
Moreover, soft tissue ﬁ  brosis and parotid atrophy resulted 
in vertical dolicholic face, while the small mandible corner 
in patient B was attributed to traumatic effect of radiotherapy 
to the cartilage of condyloid apophysis.
Many of these patients ﬁ  nally survive malignancy, but 
still suffer from severe morbidity due to the above compli-
cations, which need combined management and speciﬁ  c 
measures, such as surgical reconstruction and hormonal 
therapy.6,7 Lacey and Clarke12 recently introduced the term 
pediatric oncologic pathology to mark a new era for pediatric 
oncologists. They reported on two children with leukemia 
treated with combined radiotherapy and chemotherapy, who 
survived malignancy, but suffered in the long-term from 
bilateral SCPE or bilateral avascular femoral head necrosis, 
respectively, as a consequence of radiochemotherapy.
According to our study, we consider late sequelae in 
children with head and neck cancer due to chemoradiotherapy 
as another era for pediatric oncologic pathology in order for 
prevention, if possible, or to manage them efﬁ  ciently.
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